The 5K@ADA virtual 5K run/walk event is coming soon! Registration is open!
Registration is free.
The 5K@ADA Virtual Challenge will bring together people across the globe as well as ADA attendees to emphasize the need for increased physical activity to help prevent diabetes and diabetes complications. This disease awareness activity provides participants with the opportunity to raise public awareness about the importance of a healthy lifestyle in preventing and controlling diabetes.
The 5K@ADA is sponsored by Novo Nordisk and the American Diabetes Association (ADA). It takes place in conjunction with the ADA annual conference.
I do the walk on the treadmill at the gym. This way I can have my earbuds in, easily track my progress and not have any interruptions.
Upload your race time any time between the race start and end dates.
5K@ADA Virtual Challenge
https://www.ada5k.com/
June 18 - June 22, 2025
Registration is open. Personalized bibs are available 48 hours after signup.
Continue driving change in diabetes by running or walking the 5K@ADA in Chicago or from your home city!
The 5K@EASD virtual 5K run/walk event is coming soon! Registration opens Monday July 15.
Registration is free.
The 5K@EASD Virtual Challenge will bring together people across the globe as well as EASD attendees to emphasize the need for increased physical activity to help prevent diabetes and diabetes complications. This disease awareness activity provides participants with the opportunity to raise public awareness about the importance of a healthy lifestyle in preventing and controlling diabetes.
The 5K@EASD is sponsored by Novo Nordisk and the World Diabetes Foundation. It takes place in conjunction with the European Association for the Study of Diabetes (EASD) annual conference.
I do the walk on the treadmill at the gym. This way I can have my earbuds in, easily track my progress and not have any interruptions.
Upload your race time any time between the race start and end dates.
5K@EASD Virtual Challenge
https://www.easd5k.com/
September 7 through September 11, 2024
Registration opens July 15. Personalized bibs will be available August 7. Finisher certificates will be available September 8.
Continue driving change in diabetes by running or walking the 5K@EASD in Madrid or from your home city!
#EASD2024 #5KEASD #DiabetesAwareness #DrivingChange
Hello, fellow data analysts and fitness enthusiasts! I'm pleased to bring to your attention another fantastic opportunity to join a global movement that champions health, awareness, and community involvement: the 2024 5K@ADA Virtual Challenge!
What is the 5K@ADA?
The 5K@ADA Virtual Challenge is an inspiring event that unites people from around the world to highlight the critical importance of physical activity in preventing and managing diabetes. This event is a call to action, encouraging us to lace up our sneakers, hit our favorite trails, treadmills, or neighborhood streets, and make a significant impact in the fight against diabetes.
Why Should You Participate?
Participating in the 5K@ADA offers a unique blend of flexibility and community spirit. It's an opportunity to:
Event Details
How to Participate
Join the Movement
The 5K@ADA is more than just a virtual run/walk; it's a powerful statement about the importance of physical activity in the fight against diabetes. By participating, you're not only taking steps for your own health but also contributing to a global cause that can change lives.
So, whether you're looking to beat your personal best, enjoy a leisurely walk, or simply support a great cause, I invite you to join the 5K@ADA Virtual Challenge. Let's come together to #DriveChangeinDiabetes and show the world what we can achieve when we unite for a common goal.
Remember, every step counts, and together, we can make a significant impact. See you at the virtual starting line!
Frequently Asked Questions
Can I participate in the 5K@ADA event if I'm not a diabetic?
Yes, the 5K@ADA event is open to everyone, regardless of whether you have diabetes, to promote awareness and encourage physical activity.
Are there any age restrictions for participating in the virtual events?
The provided information does not specify age restrictions, suggesting the event is open to all ages, but it's always best to check the official event website for any age-related guidelines.
Can I walk the 5K instead of running, and does it count towards completion?
Yes, you can either run or walk the 5K distance for these virtual events, and both are considered valid forms of participation to complete the challenge.
Are there any registration fees for the 5K@ADA virtual challenge?
The announcement for the 5K@EASD indicates it's free to participate, but it's advisable to check the 5K@ADA's official website for any registration fee details.
Novo Nordisk has announced a strategic partnership with OpenAI, adding a new layer to the company’s broader artificial intelligence strategy.
This is not Novo Nordisk’s first visible move into AI. The company has already used generative AI in a more structured regulatory setting through NovoScribe, a platform designed to help produce clinical study reports and other regulatory-grade documents in a tightly controlled environment.
The new OpenAI partnership points to a broader expansion.
Rather than focusing only on a narrow, rules-based workflow, this move suggests Novo Nordisk is looking at how generative AI can support knowledge work across a larger part of the organization. That could include research support, internal knowledge access, drafting assistance, and productivity gains in areas where people spend large amounts of time working across complex information.
That shift matters.
In highly regulated industries, AI usually gains traction first in environments where the process is repeatable, the inputs are structured, and the quality checks are already clear. Regulatory documentation fits that model well. It makes sense as an early use case because the boundaries are easier to define and the risk of drift is easier to monitor.
A broader partnership with OpenAI suggests the company may now be exploring where AI can help beyond those more tightly controlled processes.
That does not mean replacing expertise or removing human oversight. If anything, it highlights the opposite. The more powerful the system, the more important governance becomes. In a setting like pharma, useful AI adoption depends on clear policies for privacy, review, accountability, and acceptable use.
This is where the contrast between Novo Nordisk’s earlier AI work and this new partnership becomes especially interesting.
The earlier project showed how AI can succeed in a process with well-defined rules and reliable guardrails. The OpenAI partnership suggests the company now wants to apply AI more broadly, while still operating within the control structure that a global healthcare company requires.
From a data and AI perspective, that's the real story.
This is not just about using a new tool. It's about organizational maturity. Companies tend to move into broader AI adoption only after they have seen where automation works, where human review remains essential, and what kind of governance needs to be in place before scaling further.
Novo Nordisk appears to be moving from targeted AI use toward a more integrated AI strategy.
For people working in data, analytics, and AI, that makes this worth watching. It offers a real-world example of how a large healthcare company may move from focused automation in one high-structure area to wider AI deployment across the enterprise.
Why this matters
For analytics professionals, this announcement stands out for three reasons:
Final Thoughts
Novo Nordisk’s new OpenAI partnership is worth paying attention to not only because of the companies involved, but because of what it may signal about the company’s next phase of AI adoption.
The earlier regulatory documentation work showed what AI can do in a tightly controlled environment. This new partnership suggests Novo Nordisk may now be extending that thinking into a wider set of business and knowledge workflows.
That makes it a useful case study for anyone interested in applied AI, enterprise governance, and how large organizations scale AI beyond isolated pilot projects.
OpenAI Partnership Sources
Novo Nordisk Press Release
Fierce Pharma Coverage
NovoScribe Sources
MongoDB Case Study: From 12 Weeks to 10 Minutes
AWS Case Study: A faster way to bring enterprise data to generative AI
Video: How Novo Nordisk Accelerates Time To Value with GenAI and MongoDB
Video: Novo Nordisk’s AI Revolution: Anthropic, MongoDB & AWS in Pharma
Page 1 of 2
